Back

NAD⁺ supplementation improves cardiomyocyte resilience to doxorubicin-induced cardiotoxicity

29 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Cardioprotection and remodelling in myocardial infarction and cardiotoxicity Stem Cells, Cell Cycle, Cell Senescence, Cell Death ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Era Gorica

University Hospital Zurich, Zurich (Switzerland)

5 More presentations in this session

Presentation thumbnail
Effect of cardiosphere-derived cell administration on cardiac function after myocardial infarction: influence of the delivery route in a relevant porcine model
Doctor V. Crisostomo (Caceres, ES)
Abstract Slides
Presentation thumbnail
Effect of renal denervation in a porcine model of myocardial infarction
Doctor D. Martinez-Falguera (Badalona, ES)
Abstract Slides
Presentation thumbnail
Anemia exacerbates regional left ventricular functional impairment and energetic imbalance in acute myocardial infarction
Mr R. Chennupati (Duesseldorf, DE)
Abstract Slides
Presentation thumbnail
Apoptosis and pyroptosis inhibitors exerted greater cardioprotection against cardiac I/R injury than ferroptosis inhibitor in prediabetic rats via an improvement of mitochondrial membrane potential
Miss N. Apaijai (Chiang Mai, TH)
Abstract Slides
Presentation thumbnail
Dual-hit with sequential isoprenaline and PD-1 blockade in A/J Mice to model immune checkpoint inhibitor-induced myocarditis
Doctor R. Van Lerberghe (Leuven, BE)
Abstract Slides

Access the full session

Session thumbnail
Cardioprotection and remodelling in myocardial infarction and cardiotoxicity

The Event

Event poster

ESC Congress 2026

29 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
In vitro platform to model anthracycline-induced cardiotoxicity and evaluate cardioprotective agents in human -induced pluripotent stem cells-derived cardiomyocytes
20 June 2025
thumbnail
Congress Presentation
Melatonin attenuates an impairment of metabolic reprogramming in doxorubicin-induced cardiotoxicity: insights from metabolomics study in rats
27 August 2023
thumbnail
ESC Journals
Breast cancer and cardiovascular health
25 September 2024
thumbnail
Congress Presentation
Polydatin, a nutraceutical agent, reduces cardiotoxicity and enhances the anticancer effects of Sunitinib through the reduction of lipid peroxidation and expression of NLRP3 inflammasome
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources